
Biochimpharm Financial Model

Biochimpharm
Biochimpharm is a biotechnology company specializing in the production of bacteriophage-based medicines aimed at combating bacterial infections. The company focuses on advancing long-term expertise in phage therapy to provide safe and effective alternatives to antibiotics.
SavvY created a financial model for a new production unit of Biochimpharm and evaluated the existing project, including investment volume, assumptions, profitability, cost structure, and revenue projections. Using a five-year financial model, the project was assessed reliably for presentation to investors.



